Stay informed with the Divis Labs Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of ...

Discover the Divis Labs Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a ...

Vinay Rajani of HDFC Securities says Divis Labs share price has broken out from the box pattern on the daily chart with the ...

Earnings call Divi's Laboratories posted a 25.4% YoY revenue growth for Q3 FY25, with PAT rising 64.5% YoY. Custom synthesis continues to drive growth, while backward integration via the new Kakinada ...

Citi said it believes Divi's Laboratories' revenue and earnings before interest, tax, depreciation, and amortisation (EBITDA) ...

Divis Laboratories shares gained 2.05% to trade at Rs 6,237.50 in Friday's session. At 10:27 am, the stock showed positive movement. Divis Laboratories is included as one of the stocks in the ...

The shares of this pharma stock, engaged in the manufacturing and exporting of API's and Nutraceutical ingredients, are in focus after leading global brokerage, CITI, has expressed its bullishness ...

On June 6, Divis Laboratories releases figures for Q4. Wall Street analysts expect Divis Laboratories will be reporting earnings per share of INR 14.95. Follow Divis Laboratories stock price in ...

Divi’s Laboratories’ (Divi’s) Q2FY26 result was in line with our expectations on all fronts. Constant currency growth slowed down to ~10.8% vs. 15% QoQ and 18% in FY25. Q2 growth was largely led by ...

Amid the rising volatility in the Indian equity markets, domestic brokerage firm BP Equities has shared its top picks for ...

Divi's Laboratories has attracted bullish sentiment from leading brokerage houses. The company’s strong fundamentals, robust R&D capabilities, and leadership position in Active Pharmaceutical ...

Earnings call Divi’s Laboratories reported Q2 FY25 consolidated revenue of ₹2,444 crore, up 22.5% YoY and 11.2% QoQ. Profit after tax rose to ₹510 crore, up 46.6% YoY. Custom synthesis now contributes ...